EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes

Mashael R Aljumaah iD, Jeffery Roach iD, Yunan Hu, John Gunstad iD, M Andrea Azcarate-Peril iD

Science Advances · 04.04.2025 · 11 (14)

DOI: 10.1126/sciadv.ads5721 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 04.04.2025. Verfasst von Mashael R Aljumaah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gastrointestinal Biology and Disease (CGIBD), Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine, UNC…. Hauptthemen laut MEDLINE: Dipeptidyl Peptidase 4, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, Host Microbial Interactions. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human dipeptidyl peptidase 4 (hDPP-4) has been a pharmacological target for metabolic diseases, particularly diabetes, since the early 2000s. As a ubiquitous enzyme found in both prokaryotic and eukaryotic organisms, hDPP-4 plays crucial roles in host homeostasis and disease progression. While many studies have explored hDPP-4’s properties, research on gut microbially derived DPP-4 (mDPP-4) remains limited. This review discusses the significance of mDPP-4 and its health implications, analyzing crystal structures of mDPP-4 in comparison to human counterparts. We examine how hDPP-4 inhibitors could influence gut microbiome composition and mDPP-4 activity. Additionally, this review connects ongoing discussions regarding DPP-4 substrate specificity and potential access routes for mDPP-4, emphasizing the urgent need for further research on mDPP-4’s role in health and improve the precision of DPP-4 inhibitor therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl Peptidase 4Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesHost Microbial InteractionsHumansSubstrate SpecificityGastrointestinal MicrobiomeIsoenzymesDipeptidyl-Peptidase IV InhibitorsAnimals

Substanzen

Dipeptidyl Peptidase 4IsoenzymesDipeptidyl-Peptidases and Tripeptidyl-PeptidasesDipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • Center for Gastrointestinal Biology and Disease (CGIBD), Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine, UNC Microbiome Core, University of North Carolina, Chapel Hill, NC, USA.
  • Department of Plant and Microbial Biology, North Carolina State University, Raleigh, NC, USA.
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Department of Psychological Sciences, Kent State University, Kent, OH, USA.

ORCID-Profile: Mashael R Aljumaah, Jeffery Roach, John Gunstad, M Andrea Azcarate-Peril

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Aljumaah, M. R., Roach, J., Hu, Y., Gunstad, J., & Azcarate-Peril, M. A. (2025). Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes. Science Advances, 11(14). https://doi.org/10.1126/sciadv.ads5721

Vancouver

Aljumaah MR, Roach J, Hu Y, Gunstad J, Azcarate-Peril MA. Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes. Science Advances. 2025;11(14). doi:10.1126/sciadv.ads5721

BibTeX
@article{Aljumaah2025,
  author = {Aljumaah, Mashael R and Roach, Jeffery and Hu, Yunan and Gunstad, John and Azcarate-Peril, M Andrea},
  title = {Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {14},
  doi = {10.1126/sciadv.ads5721}
}
Kostenlos starten →